These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4636483)

  • 21. [Seating of sales personnel in pharmacies].
    Gampe E
    Pharm Prax; 1970; 5():111-3. PubMed ID: 5455401
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug consumption and drug compensation].
    Asbrink A
    Nord Med; 1970 Sep; 84(39):1249. PubMed ID: 5469311
    [No Abstract]   [Full Text] [Related]  

  • 23. [Principles of research in consumer goods requirements].
    Schubert M
    Pharm Prax; 1972; 9():Suppl 9:193-9. PubMed ID: 5086343
    [No Abstract]   [Full Text] [Related]  

  • 24. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 26. Hybrid risk adjustment for pharmaceutical benefits.
    García-Goñi M; Ibern P; Inoriza JM
    Eur J Health Econ; 2009 Jul; 10(3):299-308. PubMed ID: 19011914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The MAC program and wholesale drug prices, a preliminary analysis.
    Dickens PF; Hogan TD
    Res Stat Note; 1977 Jul; (11):1-4. PubMed ID: 10316558
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 29. New federal guidelines: a green light from government.
    Gosselin RA
    Hosp Formul; 1978 Jul; 13(7):546-9. PubMed ID: 10308293
    [No Abstract]   [Full Text] [Related]  

  • 30. [Control--inspection].
    Schröder J; Brödner I
    Pharm Prax; 1966; 7():162-5. PubMed ID: 6001089
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceutical care in community pharmacies: practice and research in Germany.
    Eickhoff C; Schulz M
    Ann Pharmacother; 2006 Apr; 40(4):729-35. PubMed ID: 16569798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital reimbursement and clinical pharmacy programs.
    Hoffmann RP
    Hosp Pharm; 1979 Dec; 14(12):723, 726-7. PubMed ID: 10244960
    [No Abstract]   [Full Text] [Related]  

  • 33. Economic evaluation for pharmaceuticals in Germany.
    Jönsson B
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
    [No Abstract]   [Full Text] [Related]  

  • 34. What's the estimated cost of a national outpatient Rx program?
    Trapnell GR
    Pharm Times; 1980 Jan; 46(1):64-8. PubMed ID: 10245259
    [No Abstract]   [Full Text] [Related]  

  • 35. [Analytical studies into the structure and cost percentage of veterinary services in livestock production].
    Schwarz S
    Monatsh Veterinarmed; 1969 Nov; 24(21):801-6. PubMed ID: 5407853
    [No Abstract]   [Full Text] [Related]  

  • 36. Reflections on a month in the life of the Ontario Drug Benefit Plan.
    McIsaac W; Naylor CD; Anderson GM; O'Brien BJ
    CMAJ; 1994 Feb; 150(4):473-7. PubMed ID: 8313259
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative Medicaid drug cost control experiences.
    Kennard LH; Platt WG
    Med Mark Media; 1979 Mar; 14(3):38, 40-3. PubMed ID: 10316799
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug coverage under NHI policy goals--what will really work?
    Lerner I
    Hosp Formul; 1978 Aug; 13(8):596-7, 600. PubMed ID: 10308294
    [No Abstract]   [Full Text] [Related]  

  • 39. A Medicare prescription drug benefit: focusing on coverage and cost.
    Cubanski J; Kline J
    Issue Brief (Commonw Fund); 2002 Apr; (538):1-6. PubMed ID: 11993504
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of the economic effectiveness of increasing the quality of medical technology].
    Slavin MB; Ben'iash GN
    Med Tekh; 1972; 6():48-51. PubMed ID: 4661941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.